Diatherix Laboratories and Microarrays Inc. (MI) jointly announce they have entered a strategic partnership to develop industry leading infectious disease diagnostic assays.

 

The ever-increasing prevalence of infectious and drug-resistant organisms requires that diagnostic platforms be highly adaptable and progressively more comprehensive.

 

With this partnership the companies will integrate their proprietary technologies to develop and continually update diagnostic assays, which will achieve the maximum flexibility necessary to better serve the healthcare community. 

To read the full release, click here